Revenue growth collapsed from a 33.0% peak (2024Q3) to -8.6% (2026Q3) with EPS down -28.4% YoY, while the combined ratio expanded 1,280 bps sequentially to 72.1%, indicating underwriting normalization from unsustainable post-2025 pricing highs despite remaining well inside underwriting profitability thresholds.
Kinsale Capital Group, Inc. (KNSL) annual income statement — 12-year revenue, gross profit & net income history
| Metric | TTM | Dec'25 | Dec'24 | Dec'23 | Dec'22 | Dec'21 | Dec'20 | Dec'19 | Dec'18 | Dec'17 | Dec'16 | Dec'15 | Dec'14 |
|---|
| Revenue | 1.95B | 1.87B | 1.59B | 1.22B | 838.8M | 653.47M | 459.89M | 315.89M | 222.11M | 186.78M | 141.62M | 80.6M | 63.68M |
| Revenue Growth % | 8.35% | 18.04% | 29.65% | 45.98% | 28.36% | 42.09% | 45.59% | 42.22% | 18.92% | 31.89% | 75.71% | 26.57% | - |
| Medical Costs & Claims | 956.57M | 890.69M | 907.08M | 713.94M | 551.67M | 397.56M | 317.58M | 205.6M | 154.48M | 124.88M | 77.11M | 25.4M | 28.04M |
| Medical Cost Ratio % | 48.97% | 47.53% | 57.14% | 58.31% | 65.77% | 60.84% | 69.06% | 65.09% | 69.55% | 66.86% | 54.45% | 31.51% | 44.03% |
| Gross Profit | 996.72M | 983.3M | 680.44M | 510.51M | 287.13M | 255.91M | 142.31M | 110.29M | 67.64M | 61.89M | 64.51M | 55.2M | 35.64M |
| Gross Margin % | 51.03% | 52.47% | 42.86% | 41.69% | 34.23% | 39.16% | 30.94% | 34.91% | 30.45% | 33.14% | 45.55% | 68.49% | 55.97% |
| Gross Profit Growth % | - | 44.51% | 33.29% | 77.8% | 12.2% | 79.83% | 29.03% | 63.06% | 9.28% | -4.05% | 16.86% | 54.88% | - |
| Operating Expenses | 332.27M | 348.99M | 165.73M | 126.5M | 91.57M | 67.11M | 41.89M | 34.24M | 27.16M | 23.37M | 24.97M | 21.64M | 16.17M |
| OpEx / Revenue % | 17.01% | 18.62% | 10.44% | 10.33% | 10.92% | 10.27% | 9.11% | 10.84% | 12.23% | 12.51% | 17.63% | 26.85% | 25.39% |
| Depreciation & Amortization | 5.83M | 5.83M | 5.8M | 3.27M | 2.72M | 2.31M | 1.57M | 682K | 631K | 515K | 636K | 642K | 570K |
| Combined Ratio % | 65.98% | 66.15% | 67.58% | 68.64% | 76.69% | 71.11% | 78.17% | 75.92% | 81.78% | 79.38% | 72.08% | 58.36% | 69.42% |
| Operating Income | 664.45M | 634.3M | 514.72M | 384.02M | 195.56M | 188.8M | 100.41M | 76.05M | 40.48M | 38.52M | 39.54M | 33.56M | 19.47M |
| Operating Margin % | 34.02% | 33.85% | 32.42% | 31.36% | 23.31% | 28.89% | 21.83% | 24.08% | 18.22% | 20.62% | 27.92% | 41.64% | 30.58% |
| Operating Income Growth % | - | 23.23% | 34.03% | 96.36% | 3.58% | 88.02% | 32.03% | 87.87% | 5.09% | -2.57% | 17.82% | 72.33% | - |
| EBITDA | 673.45M | 640.14M | 520.52M | 387.29M | 198.28M | 191.11M | 101.99M | 76.73M | 41.11M | 39.04M | 40.17M | 34.2M | 20.04M |
| EBITDA Margin % | 34.48% | 34.16% | 32.79% | 31.63% | 23.64% | 29.25% | 22.18% | 24.29% | 18.51% | 20.9% | 28.37% | 42.43% | 31.48% |
| Interest Expense | 12.69M | 10.65M | 10.13M | 10.3M | 4.28M | 994K | 168K | 0 | 0 | 0 | 0 | 0 | 0 |
| Non-Operating Income | -6.15M | -10.65M | -10.13M | -10.3M | -4.28M | -994K | -168K | 0 | 0 | 0 | 0 | 0 | 0 |
| Pretax Income | 657.91M | 634.3M | 514.72M | 384.02M | 195.56M | 188.8M | 100.41M | 76.05M | 40.48M | 38.52M | 39.54M | 33.56M | 19.47M |
| Pretax Margin % | 33.68% | 33.85% | 32.42% | 31.36% | 23.31% | 28.89% | 21.83% | 24.08% | 18.22% | 20.62% | 27.92% | 41.64% | 30.58% |
| Income Tax | 132.73M | 130.69M | 99.87M | 75.92M | 36.45M | 36.14M | 11.99M | 12.73M | 6.69M | 13.62M | 13.37M | 11.28M | 6.5M |
| Effective Tax Rate % | 20.17% | 20.6% | 19.4% | 19.77% | 18.64% | 19.14% | 11.94% | 16.75% | 16.53% | 35.36% | 33.81% | 33.63% | 33.38% |
| Net Income | 525.18M | 503.61M | 414.84M | 308.09M | 159.11M | 152.66M | 88.42M | 63.32M | 33.79M | 24.9M | 26.17M | 22.27M | 12.97M |
| Net Margin % | 26.89% | 26.87% | 26.13% | 25.16% | 18.97% | 23.36% | 19.23% | 20.04% | 15.21% | 13.33% | 18.48% | 27.64% | 20.37% |
| Net Income Growth % | 10.78% | 21.4% | 34.65% | 93.63% | 4.23% | 72.65% | 39.65% | 87.4% | 35.69% | -4.84% | 17.48% | 71.69% | - |
| EPS (Diluted) | 23.34 | 21.65 | 17.78 | 13.22 | 6.88 | 6.62 | 3.87 | 2.86 | 1.56 | 1.16 | 1.24 | 1.06 | 0.62 |
| EPS Growth % | 12.72% | 21.77% | 34.49% | 92.15% | 3.93% | 71.06% | 35.31% | 83.33% | 34.48% | -6.45% | 16.98% | 70.97% | - |
| EPS (Basic) | - | 21.76 | 17.92 | 13.37 | 6.97 | 6.73 | 3.96 | 2.94 | 1.60 | 1.19 | 1.26 | 1.06 | 0.62 |
| Diluted Shares Outstanding | 22.5M | 23.26M | 23.33M | 23.31M | 23.13M | 23.06M | 22.85M | 22.14M | 21.68M | 21.5M | 21.07M | 20.97M | 20.97M |
Quick answers to the most common questions about buying KNSL stock.
For fiscal year 2025, Kinsale Capital Group, Inc. (KNSL) reported total revenue of $1.87B. This represents a 2843.0% increase compared to $63.7M in 2014.
Kinsale Capital Group, Inc. (KNSL) is profitable, generating $503.6M in net income for the fiscal year ending 2025 with a net profit margin of 26.9%.
Kinsale Capital Group, Inc. (KNSL) reported an operating income of $634.3M, resulting in an operating profit margin of 33.8%. This margin reflects the operational efficiency of the business before interest and taxes.
Kinsale Capital Group, Inc. (KNSL) generated $983.3M in gross profit for the year, representing a gross profit margin of 52.5%. This demonstrates the company's core pricing power and production efficiency.
Key Metrics
Top Statement Risk
Social inflation undermining casualty reserve adequacy
Metrics are mathematically derived from official filings.
Growth Deceleration Sharpens into Contraction
KNSL's quarterly revenue growth trajectory has deteriorated from a peak of 33.0% in 2024Q3 to -8.6% in 2026Q3, representing a complete reversal from aggressive expansion to top-line contraction. This trajectory shift warrants close examination of whether it reflects disciplined underwriting restraint or market share loss.
The ten-quarter revenue growth pattern shows a clear parabolic arc — accelerating through 2024 (30.0%, 33.0%, 17.4%), maintaining strength in 2025 (13.6% to 22.2% range), then decelerating sharply in 2026 (10.2%, 16.8%, -8.6%). The negative print in Q3 2026 is the first contraction in the series and breaks the multi-year growth narrative. This could indicate that the hard E&S market is beginning to soften, that Kinsale is voluntarily reducing premium volume to protect risk quality, or that competitive pressures from larger carriers are intensifying — the distinction has material implications for forward earnings power. Management's emphasis on 'disciplined underwriting' in recent commentary may be reframing a slowdown as intentional selectivity, but the pace of the deceleration from double-digit to negative growth in consecutive quarters appears more abrupt than typical underwriting discipline would produce.
Underwriting Profitability Undergoes Meaningful Correction
The combined ratio expanded from an exceptionally favorable 59.3% in 2026Q2 to 72.1% in 2026Q3, an 1280-basis-point swing in a single quarter. While both readings remain well below the 100% underwriting breakeven, the magnitude of deterioration suggests changing loss experience or pricing dynamics that merit scrutiny.
The loss ratio tells a more concentrated story: it surged from 42.1% in 2026Q2 to 51.0% in 2026Q3, a 890-basis-point increase. The 2026Q2 loss ratio of 42.1% was the lowest in the entire ten-quarter series and may have represented a period of unusually favorable reserve development or absent catastrophe losses rather than sustainable underwriting performance. Comparing the 72.1% combined ratio in Q3 2026 to the 73.5% reading in 2025Q1 — which was similarly elevated — suggests a recurring pattern where certain quarters experience loss ratio spikes that temporarily compress underwriting margins. Given that Kinsale's underwriting spread (the gap between its combined ratio and peers like RLI and Skyward) is central to its premium valuation, even a modest sustained shift toward the mid-70s combined ratio could meaningfully compress return on equity assumptions embedded in the current share price.
Loss Ratio Volatility Signals Reserve Uncertainty
KNSL's loss ratio has swung across a 1,140-basis-point range over ten quarters, from a low of 42.1% in 2026Q2 to a high of 63.5% in 2025Q1. Such pronounced volatility in a specialty casualty-heavy book raises questions about the stability of reserve adequacy assumptions.
Specialty E&S insurers writing predominantly casualty lines should theoretically exhibit smoother loss ratio trajectories than property-heavy peers, given that casualty claims develop over longer tail periods and are less subject to discrete catastrophe events. The observed volatility — alternating between quarters near 42-45% and quarters near 60-64% — may indicate that reserve releases in favorable quarters are partially offsetting adverse development in others, or that a growing property lines allocation is introducing episodic catastrophe exposure. The 2026Q1 loss ratio of 60.1% and 2025Q1 at 63.5% both represent elevated readings that could reflect either genuine accident year deterioration or prior-period reserve strengthening. Investors should examine whether the low loss ratio quarters are being driven by accident year improvement or by favorable prior-year development, as the distinction between organic underwriting profit and reserve release-driven earnings is critical for assessing sustainability.
Q2 2026 Peak Gives Way to Sharper Reset
The Q2 2026 to Q3 2026 transition represents the most dramatic single-quarter inflection in Kinsale's ten-quarter history: EPS declined from $7.72 to $4.36 (a 43.5% sequential drop), combined ratio deteriorated 1,280 basis points, and revenue contracted 8.6% year-over-year. The reversal appears abrupt relative to the preceding trend.
The Q2 2026 earnings beat ($7.72 actual vs. $4.94 estimated) was driven by a combination of factors that now appear difficult to replicate: a 42.1% loss ratio, a 59.3% combined ratio, and $548.5M in quarterly revenue. Q3 2026's retreat to a 72.1% combined ratio and $4.36 EPS suggests the Q2 result may have reflected favorable reserve development or timing effects rather than a step-change in underlying profitability. Sequential EPS decline of 43.5% from the Q2 peak is not merely a reversion to trend — it falls below the $4.90 EPS recorded in 2024Q3, implying that on a year-over-year basis, underlying earnings power may be flat to lower despite the substantial revenue growth over the same period. The $250M buyback authorization announced alongside the Q2 beat may have anchored market expectations to peak-cycle earnings, making the Q3 reversion a particularly sensitive event for forward multiple compression risk.
Tech Premium Faces Underwriting Cycle Reality
KNSL's premium valuation relative to specialty peers like RLI (14.87x P/E) and SKWD (14.84x P/E) embeds an assumption of perpetual mid-teens growth and sub-70% combined ratios. The Q3 2026 contraction of -8.6% in revenue and -28.4% in EPS growth challenges whether the technology moat truly insulates KNSL from the P&C pricing cycle.
The prevailing bull thesis positions Kinsale as a structural compounder whose automated underwriting platform provides a permanent cost advantage over legacy carriers. However, the Q3 2026 data introduces the possibility that the company's premium growth and margin expansion were substantially a function of the hard market cycle rather than technology alone — the E&S space benefits counter-cyclically from admitted market retrenchment, which may be reversing. If the admitted market begins recapturing business or if E&S pricing normalizes, Kinsale's technology advantage translates into a lower cost base but does not prevent loss ratio deterioration from competitive rate pressure. Furthermore, social inflation — accelerating litigation costs and nuclear jury verdicts in casualty lines — represents a tail risk that Kinsale's underwriting technology cannot algorithmically mitigate; historical reserve adequacy is not predictive of future performance when the underlying loss environment is shifting. The wide loss ratio dispersion observed over ten quarters (42.1% to 63.5%) may foreshadow increased earnings volatility as the company's property lines allocation grows, introducing binary catastrophe exposure that contradicts the smooth-growth narrative supporting the current valuation.